Ledger.Open graph →
SEC Form D · filed June 30, 2023

TwinStrand Biosciences, Inc

Offering
$25.7M
Sold
$10.3M
Exemption
Rule 506(b)
Industry
Other Technology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Mike Pellini · Los Angeles, CADirectorJason Myers · Davie, FLDirectorKaren Dabbs · Seattle, WAExecSoma Somasegar · SEATTLE, WADirectorDavid Canner · Mendham, NJDirectorRonnie Andrews · Alpharetta, GAExecChad Waite · Somerville, MADirectorMike Pellini · Los Angeles, CADirectorJason Myers · Redwood City, CADirectorKaren Dabbs · Seattle, WAExecSoma Somasegar · SEATTLE, WADirectorDavid Canner · Mendham, NJDirectorRonnie Andrews · SEATTLE, WAExecChad Waite · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗